CA2244608A1 - Produit nutritionnel riche en matieres grasses, faible en glucides et ayant un desequilibre en acides amines - Google Patents
Produit nutritionnel riche en matieres grasses, faible en glucides et ayant un desequilibre en acides aminesInfo
- Publication number
- CA2244608A1 CA2244608A1 CA002244608A CA2244608A CA2244608A1 CA 2244608 A1 CA2244608 A1 CA 2244608A1 CA 002244608 A CA002244608 A CA 002244608A CA 2244608 A CA2244608 A CA 2244608A CA 2244608 A1 CA2244608 A1 CA 2244608A1
- Authority
- CA
- Canada
- Prior art keywords
- nutritional product
- amino acid
- high fat
- low carbohydrate
- acid imbalance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001413 amino acids Chemical class 0.000 title abstract 2
- 150000001720 carbohydrates Chemical class 0.000 title abstract 2
- 235000016709 nutrition Nutrition 0.000 title abstract 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 abstract 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 abstract 2
- QDGAVODICPCDMU-UHFFFAOYSA-N 2-amino-3-[3-[bis(2-chloroethyl)amino]phenyl]propanoic acid Chemical compound OC(=O)C(N)CC1=CC=CC(N(CCCl)CCCl)=C1 QDGAVODICPCDMU-UHFFFAOYSA-N 0.000 abstract 1
- FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 abstract 1
- 235000019454 L-leucine Nutrition 0.000 abstract 1
- 239000004395 L-leucine Substances 0.000 abstract 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 abstract 1
- 229930195722 L-methionine Natural products 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 229940024606 amino acid Drugs 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 230000005907 cancer growth Effects 0.000 abstract 1
- 229960003136 leucine Drugs 0.000 abstract 1
- 229960004452 methionine Drugs 0.000 abstract 1
- 238000011275 oncology therapy Methods 0.000 abstract 1
- 229960004441 tyrosine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/997,837 US5817695A (en) | 1997-12-24 | 1997-12-24 | Nutritional product with high fat, low carbohydrate and amino acid imbalance |
US08/997,837 | 1997-12-24 |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2244608A1 true CA2244608A1 (fr) | 1999-06-24 |
CA2244608C CA2244608C (fr) | 2002-12-17 |
Family
ID=25544458
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002244608A Expired - Fee Related CA2244608C (fr) | 1997-12-24 | 1998-07-31 | Produit nutritionnel riche en matieres grasses, faible en glucides et ayant un desequilibre en acides amines |
Country Status (5)
Country | Link |
---|---|
US (1) | US5817695A (fr) |
EP (1) | EP0925726B1 (fr) |
CA (1) | CA2244608C (fr) |
DE (1) | DE69821329T2 (fr) |
ES (1) | ES2215278T3 (fr) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6322826B2 (en) * | 1998-06-16 | 2001-11-27 | Mathias Christian Zohoungbogbo | Dietetic food composition and dietetic method using such composition |
EP0951842B1 (fr) * | 1999-01-20 | 2002-12-04 | N.V. Nutricia | Aliment pour bébé |
US20020132781A1 (en) * | 2000-10-06 | 2002-09-19 | George Kindness | Combination and method of treatment of cancer utilizing a COX-2 inhibitor and A 3-hydroxy-3-methylglutaryl-coenzyme-A (HMG-CoA) reductase inhibitor |
US6506412B2 (en) * | 2000-11-29 | 2003-01-14 | Sciencebased Health | Treatment of dry eye syndrome |
US20030129262A1 (en) * | 2001-08-30 | 2003-07-10 | Epner Daniel E. | Methionine restriction for cancer therapy |
US20030105104A1 (en) * | 2001-11-27 | 2003-06-05 | Burzynski Stanislaw R. | Formulation of amino acids and riboflavin useful to reduce toxic effects of cytotoxic chemotherapy |
US6939860B2 (en) * | 2002-01-08 | 2005-09-06 | Matthias Rath | Composition and method for treatment of neoplastic diseases associated with elevated matrix metalloproteinase activities using catechin compounds |
CA2471932A1 (fr) * | 2002-01-11 | 2003-07-17 | Matthias Rath | Formulation pharmaceutique d'elements nutritifs contenant des polyphenols et son utilisation dans le traitement du cancer |
ATE383076T1 (de) * | 2002-02-04 | 2008-01-15 | Bristol Myers Squibb Co | Muttermilchzusatz |
JP4664071B2 (ja) * | 2002-08-01 | 2011-04-06 | エーザイ コーポレーション オブ ノース アメリカ | グルタミンによるガンの改良治療 |
US20040087490A1 (en) * | 2002-09-20 | 2004-05-06 | Troup John P. | Nutritional compositions |
US20040091518A1 (en) * | 2002-11-07 | 2004-05-13 | Welser Jennifer L. | Lysine mixture and apparatus and method for administering lysine |
US20040120983A1 (en) * | 2002-12-23 | 2004-06-24 | Philip Connolly | Nutritional supplement |
US20050118235A1 (en) * | 2003-12-02 | 2005-06-02 | Shiguang Yu | Dietary non-essential amino acid tyrosine regulates the body weight of animals through regulating the animal appetite or food intake |
AU2006263652B2 (en) * | 2005-06-29 | 2010-06-17 | Hill's Pet Nutrition, Inc. | Methods and compositions for the prevention and treatment of inflammatory disease |
CA2631647A1 (fr) * | 2005-11-30 | 2007-06-07 | Nestec S.A. | Emploi d'acides amines a chaine ramifiee pour traiter la perte musculaire |
US8143235B2 (en) * | 2005-12-16 | 2012-03-27 | N.V. Nutricia | Use of dietary fibres against muscle wasting |
DE102007013903A1 (de) * | 2007-03-20 | 2008-09-25 | Coy, Johannes F., Dr. | Getränk |
EP2135604A4 (fr) * | 2007-03-26 | 2011-08-03 | Hirofumi Matsui | Préparation de perfusion pour patient souffrant du cancer |
WO2011045810A1 (fr) | 2009-08-13 | 2011-04-21 | Zota Health Care Limited | Compositions pharmaceutiques contenant de la taurine et de la race-méthionine pour le traitement de l'alcoolisme |
WO2013124860A1 (fr) | 2012-02-23 | 2013-08-29 | Zota Health Care Ltd | Formulation revitalisante puissante |
WO2015177805A1 (fr) | 2014-05-19 | 2015-11-26 | Zota Health Care Ltd | Combinaison de taurine et de raceméthionine pour le traitement de maladies hépatiques |
US11344497B1 (en) | 2017-12-08 | 2022-05-31 | Quicksilver Scientific, Inc. | Mitochondrial performance enhancement nanoemulsion |
US10722465B1 (en) | 2017-12-08 | 2020-07-28 | Quicksilber Scientific, Inc. | Transparent colloidal vitamin supplement |
US11291702B1 (en) | 2019-04-15 | 2022-04-05 | Quicksilver Scientific, Inc. | Liver activation nanoemulsion, solid binding composition, and toxin excretion enhancement method |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5081105A (en) * | 1988-01-15 | 1992-01-14 | New England Deaconess Hospital Corporation | Method of treating cancer using structured lipids |
JPH01301619A (ja) * | 1988-05-30 | 1989-12-05 | Otsuka Pharmaceut Factory Inc | 癌用アミノ酸製剤 |
US5132113A (en) * | 1990-10-26 | 1992-07-21 | Maurizio Luca | Nutritional composition containing essential amino acids |
JP3429327B2 (ja) * | 1992-07-20 | 2003-07-22 | 味の素ファルマ株式会社 | 癌用アミノ酸輸液剤 |
US5547927A (en) * | 1993-05-28 | 1996-08-20 | Abbott Laboratories | Enteral nutritional product for patients undergoing radiation therapy and/or chemotherapy |
US5661123A (en) * | 1995-01-17 | 1997-08-26 | Nestec, Ltd. | Enteral composition for malabsorbing patients |
-
1997
- 1997-12-24 US US08/997,837 patent/US5817695A/en not_active Expired - Lifetime
-
1998
- 1998-07-31 CA CA002244608A patent/CA2244608C/fr not_active Expired - Fee Related
- 1998-10-02 DE DE1998621329 patent/DE69821329T2/de not_active Expired - Lifetime
- 1998-10-02 ES ES98308062T patent/ES2215278T3/es not_active Expired - Lifetime
- 1998-10-02 EP EP98308062A patent/EP0925726B1/fr not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0925726B1 (fr) | 2004-01-28 |
DE69821329D1 (de) | 2004-03-04 |
EP0925726A1 (fr) | 1999-06-30 |
DE69821329T2 (de) | 2004-11-18 |
CA2244608C (fr) | 2002-12-17 |
ES2215278T3 (es) | 2004-10-01 |
US5817695A (en) | 1998-10-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2244608A1 (fr) | Produit nutritionnel riche en matieres grasses, faible en glucides et ayant un desequilibre en acides amines | |
EP0764405B1 (fr) | Composition nutritive | |
CA2128078A1 (fr) | Produit alimentaire pour patients ayant subi un traumatisme ou une intervention chirurgicale | |
EP0044032B2 (fr) | Méthode pour produire une composition de peptides à bas poids moléculaire et agent nutritif contenant celle-ci | |
ZA849312B (en) | Dietetic supplement and prepackaged food in which it is contained.process of preparation and method of administration | |
NZ310705A (en) | High moisture nutrient formulation containing at least 50% water, at least 8% digestible carbohydrates and at least 7% of an amino acid source | |
US5756481A (en) | Composition based on amino acids intended for the treatment of sepsis or of an attack bringing about an inflammatory reaction in animals and man | |
AU5763094A (en) | Composition and method for treating patients with hepatic disease | |
CA2331854A1 (fr) | Produit nutritionnel pour personne presentant une insuffisance renale | |
PT83983B (pt) | Processo para a preparacao de concentrados de bebidas contendo um suplemento nutritivo de calcio | |
CA2385860A1 (fr) | Composition comprenant des proteines de caseine et de petit lait | |
CA2318566A1 (fr) | Aliments gelifies et procede de fabrication | |
AU4003999A (en) | Healthbar formulations | |
CA2054358A1 (fr) | Formulations nutritives tres acides | |
CA2221455A1 (fr) | Compositions pharmaceutiques et/ou dietetiques possedant une activite antioxydante et contenant de la carnosine ou ses derives et des acides amines ramifies | |
IL128153A0 (en) | Nutritional formula for phenylketonuria patients | |
CA2320991A1 (fr) | Composition nutritionnelle riche en calories | |
AU5767390A (en) | Improved nutritional formulation for the treatment of renal disease | |
EP0680945A3 (fr) | Amino acide, carnithine et magnésium supplémentation | |
WO1999048384A3 (fr) | Aliments contenant de la biotine et autres vitamines b | |
CA2251916A1 (fr) | Additif utilise dans tout type de complements energetiques, utilisation d'un hydrolysat de proteines dans la preparation d'un complement energetique, et complement energetique comprenant cet additif | |
CA2134380C (fr) | Composition a base d'acides amines servant au traitement de la septicemie ou d'une atteinte induisant une reaction inflammatoire | |
Chang | The future prospect of traditional Korean fermented foods | |
Jung et al. | Inhibition of aromatic amino acid decarboxylase and depletion of biogenic amines in brain of rats treated with alpha-monofluoromethyl p-tyrosine: similitudes and differences with the effects of alpha-monofluoromethyldopa | |
ES8704330A1 (es) | Procedimiento de preparar y almacenar composiciones comestibles edulcoradas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |
Effective date: 20160801 |
|
MKLA | Lapsed |
Effective date: 20160801 |